HouseMyDog has merged with fellow dog walking and sitting service provider Gudog, which counts Wayra among its investors.

The streaming platform has expanded its podcast content with the purchase of GV-backed Anchor, just days after buying Gimlet Media for more than $200m.

The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.

Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.

6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.

VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.

The streaming platform is in advanced talks to acquire podcast producer Gimlet Media, which has raised $27m from investors including WPP and Graham Holdings, for more than $200m.

Demisto, a cybersecurity technology developer that has raised $69m from investors including Slack and Wipro, is reportedly in talks concerning an acquisition by Palo Alto Networks.

REV-backed Palantir has cut the size of its stock options, effectively valuing itself at $11bn just four months after reports suggested it would seek a $41bn valuation for its IPO in 2019.

In-game communication platform Vivox has been acquired by game development technology provider Unity after raising more than $16m from investors including Peacock Equity.